Allogene Therapeutics Inc (ALLO)
R&D Expense Growth
-4.01%
Quarterly · Period ending:
ALLO R&D Expense Growth
Latest reported-4.01%period ending
Latest reported-4.01%period ending
ALLO Quarterly R&D Growth (QoQ) (0.00% → -4.01%)
Latest values, visible window
High-resolution chart · PNG
ALLO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -4.0059% | |
| 11.7735% | |
| -8.1248% | |
| -22.3927% | |
| -20.008% | |
| 11.625% | |
| 0.5792% | |
| -11.2044% | |
| -3.6434% | |
| -4.3944% | |
| 18.8877% | |
| -25.889% | |
| -22.6825% | |
| 6.3896% | |
| 18.5069% | |
| 11.3169% | |
| -4.9621% | |
| 11.4351% | |
| -8.0671% | |
| 12.2968% | |
| -5.2426% | |
| 5.6579% | |
| 1.5694% | |
| 8.7217% | |
| 12.497% | |
| -14.8309% | |
| 23.4229% | |
| 25.8734% | |
| 35.7689% | |
| 26.4754% | |
| 70.23% | |
| -91.1255% | |
| 0% | |
| 0% | |
| 0% |